What are the side effects of propranolol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propranolol Side Effects

Propranolol causes a wide range of adverse effects across multiple organ systems, with the most clinically significant being cardiovascular (bradycardia, hypotension), respiratory (bronchospasm), metabolic (hypoglycemia, especially in children), and central nervous system effects (sleep disturbances, lethargy, nightmares). 1

Cardiovascular Side Effects

  • Bradycardia and hypotension are the most common cardiovascular effects due to beta-receptor blockade, occurring frequently but typically remaining mild and asymptomatic in patients without cardiac comorbidities 2, 3
  • Cold extremities and arterial insufficiency (Raynaud-type) result from peripheral vasoconstriction and occur commonly 1, 3
  • Intensification of AV block, congestive heart failure, and paresthesia of hands can occur 1
  • Thrombocytopenic purpura has been reported 1

Clinical Pitfall: While bradycardia and hypotension are expected, clinically symptomatic cases requiring intervention are uncommon (0.1% for bradycardia in one large pediatric series) 2

Respiratory Side Effects

  • Propranolol is absolutely contraindicated in asthma and should be used with extreme caution in chronic obstructive pulmonary disease due to β₂-receptor blockade causing bronchoconstriction 3, 1
  • Bronchial irritation, hyperreactivity, bronchospasm, and cold-induced wheezing occur in 3-13% of patients 2, 3
  • Respiratory adverse effects may require temporary discontinuation or dose reduction 2

Critical Warning: Propranolol does NOT cause isolated rhinorrhea—if a patient develops a runny nose, investigate alternative causes such as viral infection, allergic rhinitis, or other medications 3

Central Nervous System and Psychiatric Effects

  • Sleep disturbances are common (2-18.5% of patients), including insomnia, nightmares, night terrors, and nocturnal agitation, due to propranolol's lipophilic properties allowing blood-brain barrier penetration 2, 3, 4
  • Lethargy and fatigue are dose-related effects that appear more pronounced in elderly patients and those with reduced hepatic clearance 5, 1
  • Mental depression manifested by lassitude and weakness occurs 1
  • Visual disturbances, hallucinations, and vivid dreams are reported 1
  • An acute reversible syndrome characterized by disorientation, short-term memory loss, emotional lability, and clouded sensorium can occur 1

Management Strategy for Sleep Disturbances: Consider dose reduction, earlier-evening dosing to minimize nighttime effects, or switching to a less lipophilic beta-blocker with reduced blood-brain barrier penetration 4, 5

Metabolic and Endocrine Effects

  • Hypoglycemia is particularly dangerous in infants and children, occurring due to effects on glycogenolysis and gluconeogenesis 2, 1
  • Beta-blockade masks early warning signs of hypoglycemia (sweating, tachycardia, shakiness), while late manifestations include lethargy, poor feeding, apnea, seizures, and loss of consciousness 2
  • Hypoglycemia risk increases during fasting (including preoperative periods), after prolonged exercise, and in patients with renal insufficiency 3, 1
  • Hyperglycemia has also been reported 3
  • Propranolol may mask clinical signs of hyperthyroidism and alter thyroid function tests (increasing T4 and reverse T3, decreasing T3) 1

Critical Safety Measure in Pediatrics: Administer oral propranolol with feeds and hold therapy during periods of restricted oral intake to prevent hypoglycemia and hypoglycemia-induced seizures 2

Gastrointestinal Effects

  • Nausea, vomiting, epigastric distress, abdominal cramping, diarrhea, and constipation are common 1
  • Rare but serious: mesenteric arterial thrombosis and ischemic colitis 1
  • Gastrointestinal symptoms tend to be dose-dependent and may respond to cautious dose reduction 3

Musculoskeletal Effects

  • Musculoskeletal aches and pain, predominantly involving the legs and feet, are dose-dependent and often respond to dose reduction 3, 1

Dermatologic and Allergic Reactions

  • Hypersensitivity reactions including anaphylactic/anaphylactoid reactions have been reported 1
  • Serious cutaneous reactions: Stevens-Johnson Syndrome, toxic epidermal necrolysis, exfoliative dermatitis, erythema multiforme 1
  • Urticaria, alopecia, SLE-like reactions, and psoriasiform rashes occur 1
  • Dry eyes have been reported 1

Hematologic Effects

  • Agranulocytosis (with pharyngitis, fever, aching, and sore throat) 1
  • Thrombocytopenic and nonthrombocytopenic purpura 1

Genitourinary Effects

  • Male impotence and Peyronie's disease are recognized adverse effects 1

Special Warnings and Severe Toxicity

  • Abrupt discontinuation can cause exacerbation of angina, myocardial infarction, or thyroid storm—always taper gradually over at least several weeks 1
  • In overdose (≥2,000 mg in isolated ingestions), severe toxicity occurs in approximately 50% of cases, including seizures, coma, cardiac arrest, and death 6
  • Severe toxicity in overdose includes seizures (8%), coma (14%), need for inotropes (20%), sodium channel blockade (8%), and cardiac arrest (3%) 6

Dose-Related Patterns

  • Fatigue, lethargy, and vivid dreams are dose-related with immediate-release formulations 1
  • Both nausea and musculoskeletal symptoms respond to reducing propranolol to the smallest effective dose 3

Patient Education Priorities

Clinicians must educate caregivers and patients about: 2

  • Sleep disturbances and their management options
  • Bronchial irritation and when to seek care
  • Signs of clinically symptomatic bradycardia and hypotension
  • Hypoglycemia risk and the importance of taking medication with food (especially in children)

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Propranolol Side Effects and Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Propranolol's Impact on Sleep

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Propranolol-Induced Lethargy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is Propranolol?
What is the time to death after a propranolol (beta blocker) overdose?
Can a patient feel pain in a propranolol (propranolol) overdose without significant central nervous system depression?
Can propranolol (beta blocker) cause nausea or muscle tension in patients?
In an adult who has recently started propranolol (40–80 mg twice daily), can the drug cause rhinorrhea (runny nose)?
In a patient with unresectable, transplant‑ineligible hepatocellular carcinoma, preserved liver function (Child‑Pugh A or early B), limited tumor burden (up to three lesions ≤5 cm each or a single lesion ≤8 cm) and no main portal vein thrombosis, what are the eligibility criteria, required baseline work‑up (contrast‑enhanced MRI or multiphase CT, technetium‑99m macro‑aggregated albumin scan, liver function panel, ECOG performance status), procedural steps, post‑procedure monitoring, and contraindications for trans‑arterial radio‑embolization (TARE)?
What is the mechanism of action of lithium?
What is the appropriate emergency management for a 2‑month‑old infant presenting with hyperglycemia, hyponatremia, watery diarrhea and respiratory distress?
What is dyshidrotic eczema?
Which guideline defines the lesion‑size criteria (up to three lesions ≤5 cm or a single lesion ≤8 cm) for trans‑arterial radio‑embolization in unresectable, transplant‑ineligible hepatocellular carcinoma with preserved Child‑Pugh A/early B liver function and no main portal‑vein thrombosis?
What is the appropriate immediate management for an adult patient with sepsis (elevated procalcitonin, leukocytosis with neutrophilia), hyperchloremic metabolic acidosis, acute kidney injury (elevated BUN and creatinine, reduced estimated glomerular filtration rate), hyperglycemia, hypocalcemia, and microcytic hypochromic anemia with high red cell distribution width?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.